Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
IBER.U was delisted on the 1st of March, 2023.
10 hedge funds and large institutions have $4.01M invested in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 4 closing their positions.
23% less funds holding
Funds holding: 13 → 10 (-3)
34% less capital invested
Capital invested by funds: $6.12M → $4.01M (-$2.11M)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Wealthspring Capital
West Harrison,
New York
|
-$1.77M |
| 2 |
CS
Clear Street
New York
|
-$157K |
| 3 |
E
Ergoteles
New York
|
-$137K |
| 4 |
Jane Street
New York
|
-$117K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$94K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SIA
1
Schechter Investment Advisors
Birmingham,
Michigan
| $1.75M | -$16K | -1,600 | -0.9% |
|
|
HF
2
HRT Financial
New York
| $649K | – | – | – |
|
|
3
Jane Street
New York
| $573K | -$117K | -11,707 | -17% |
|
|
LCM
4
Landscape Capital Management
Englewood,
New Jersey
| $366K | – | – | – |
|
|
TAM
5
Terrapin Asset Management
Miami,
Florida
| $186K | +$185K | +18,510 | New |
|
|
WC
6
Wealthspring Capital
West Harrison,
New York
| $180K | -$1.77M | -177,162 | -91% |
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $159K | -$18K | -1,800 | -10% |
|
|
SMA
8
Sage Mountain Advisors
Atlanta,
Georgia
| $132K | -$8.18K | -820 | -6% |
|
|
GCL
9
Glazer Capital LLC
New York
| $10K | – | – | – |
|
10
UBS Group
Zurich,
Switzerland
| $5.98K | – | – | – |
|
|
CS
11
Clear Street
New York
| – | -$157K | -15,839 | Closed |
|
|
E
12
Ergoteles
New York
| – | -$137K | -13,850 | Closed |
|
|
WAM
13
Wolverine Asset Management
Chicago,
Illinois
| – | -$94K | -9,500 | Closed |
|
|
CCM
14
Condor Capital Management
Martinsville,
New Jersey
| – | -$20K | -2,030 | Closed |
|
IBER.U Hedge Fund Activity: Q4 2022 in Review
10 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) for Q4 2022, worth a combined $4.01M — down 34% from $6.12M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of IBER.U and 1 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 0 added.
The largest seller was Wealthspring Capital, cutting an estimated $1.77M.
- 10 institutional investors held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) as of Q4 2022, down from 13 in Q3 2022.
- Funds reported $4.01M of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant stock for Q4 2022, down 34% quarter-over-quarter.
- 1 fund opened new Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant positions in Q4 2022 and 4 closed out, a net change of -3 holders.
- The largest Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant seller in Q4 2022 was Wealthspring Capital, an estimated $1.77M sold.
Based on aggregated 13F filings for Q4 2022.